Explore how PROTACs - protein-degrading molecules - could transform antithrombotic therapy by targeting platelets, offering safer blood clot prevention with reduced bleeding risks.
Explore how BRD4-targeting PROTACs are transforming multiple myeloma treatment through targeted protein degradation technology.
Explore how PROTAC technology revolutionizes protein degradation and how scientists confirmed pirin binding in cancer cells using innovative molecular approaches.